| Meningeal inflammation and cortical demyelination in acute multiple sclerosis RJ Bevan, R Evans, L Griffiths, LM Watkins, MI Rees, R Magliozzi, I Allen, ... Annals of neurology 84 (6), 829-842, 2018 | 134 | 2018 |
| Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis S Loveless, JW Neal, OW Howell, KE Harding, P Sarkies, R Evans, ... Brain Pathology 28 (4), 507-520, 2018 | 49 | 2018 |
| Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models SM Carpanini, M Torvell, RJ Bevan, RAJ Byrne, N Daskoulidou, T Saito, ... Acta Neuropathologica Communications 10 (1), 99, 2022 | 47 | 2022 |
| Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer’s disease RJ Bevan, TR Hughes, PA Williams, MA Good, BP Morgan, JE Morgan Acta Neuropathologica Communications 8 (1), 216, 2020 | 40 | 2020 |
| Microglial morphometric analysis: so many options, so little consistency J Reddaway, PE Richardson, RJ Bevan, J Stoneman, M Palombo Frontiers in neuroinformatics 17, 1211188, 2023 | 38 | 2023 |
| The impact of probiotic supplementation on cognitive, pathological and metabolic markers in a transgenic mouse model of Alzheimer’s disease TS Webberley, G Masetti, RJ Bevan, J Kerry-Smith, AA Jack, DR Michael, ... Frontiers in Neuroscience 16, 843105, 2022 | 29 | 2022 |
| The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome BJ Cooze, M Dickerson, R Loganathan, LM Watkins, E Grounds, ... Brain Pathology 32 (5), e13054, 2022 | 25 | 2022 |
| Expression and function of NOD-like receptors by human term gestation-associated tissues AH Bryant, RJ Bevan, S Spencer-Harty, LM Scott, RH Jones, CA Thornton Placenta 58, 25-32, 2017 | 23 | 2017 |
| Substantial subpial cortical demyelination in progressive multiple sclerosis: have we underestimated the extent of cortical pathology L Griffiths, R Reynolds, R Evans, RJ Bevan, MI Rees, D Gveric, JW Neal, ... Neuroimmunol Neuroinflammation 7, 51-67, 2020 | 19 | 2020 |
| Textural feature analysis of optical coherence tomography phantoms M Kulmaganbetov, RJ Bevan, N Anantrasirichai, A Achim, I Erchova, ... Electronics 11 (4), 669, 2022 | 16 | 2022 |
| Assessment of Lab4P probiotic effects on cognition in 3xTg-AD Alzheimer’s disease model mice and the SH-SY5Y neuronal cell line TS Webberley, RJ Bevan, J Kerry-Smith, J Dally, DR Michael, S Thomas, ... International Journal of Molecular Sciences 24 (5), 4683, 2023 | 15 | 2023 |
| OPA1 deficiency accelerates hippocampal synaptic remodelling and age-related deficits in learning and memory RJ Bevan, PA Williams, CT Waters, R Thirgood, A Mui, S Seto, M Good, ... Brain Communications 2 (2), fcaa101, 2020 | 12 | 2020 |
| Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia WM Zelek, RJ Bevan, BP Morgan Brain, Behavior, and Immunity 118, 355-363, 2024 | 2 | 2024 |
| Improved DiOlistic labelling technique for neurons in situ: Detailed visualisation of dendritic spines and concurrent histochemical-detection in fixed tissue RJ Bevan, G Cimaglia, JE Morgan, PR Taylor Methods 229, 82-93, 2024 | 1 | 2024 |
| Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer’s disease mouse model WM Zelek, RJ Bevan, J Nimmo, M Dewilde, B De Strooper, BP Morgan Brain, awae278, 2024 | 1 | 2024 |
| Uncoupling of synaptic loss from amyloid burden by an Alzheimer’s disease protective variant of PLCγ2 RJ Bevan, E Maguire, T Phillips, E Simonazzi, M Vassileva, J Williams, ... BioRxiv, 2023.09. 22.558987, 2023 | 1 | 2023 |
| Gene gun DiOlistic labelling of retinal ganglion cells G Cimaglia, RJ Bevan, A Want, JE Morgan Retinal Ganglion Cells: Methods and Protocols, 33-40, 2023 | 1 | 2023 |
| SVM-Based Optical Detection of Retinal Ganglion Cell Apoptosis M Kulmaganbetov, R Bevan, A Want, N Anantrasirichai, A Achim, J Albon, ... Photonics 12 (2), 128, 2025 | | 2025 |
| Targeting novel anti‐complement drugs to the brain reduces complement activation and synapse loss, and improves cognition in a mouse model of dementia WM Zelek, RJ Bevan, JM Nimo, M Dewilde, B De Strooper, BP Morgan Alzheimer's & Dementia 20, e090708, 2024 | | 2024 |
| Retinal ganglion cell subtypes and their vulnerability in glaucoma JE Morgan, RJ Bevan, G Cimaglia Glaucoma: Methods and Protocols, 191-205, 2024 | | 2024 |